Hill-Rom picks up wearable ventilator maker in $130M deal

The medical equipment and systems company announced it's adding Breathe Technologies to its respiratory care business, part of a unit that contributed to Hill-Rom's 3% quarterly revenue growth reported Friday.

By Maria Rachal • Aug. 2, 2019

Exact Sciences to gain breast, prostate cancer tests in $2.8B deal

The Cologuard maker is adding Genomic Health's Oncotype DX tests to its ranks, which together target a market worth an estimated $20 billion.

By Maria Rachal • July 29, 2019

Healthcare the lone growth driver for 3M in Q2

The unit posted 5.8% sales growth, providing some relief for the beleaguered conglomerate, which expects its $6.7 billion buyout of wound care company Acelity to close in the fourth quarter.

By Nick Paul Taylor • July 26, 2019

Quest reports volume growth despite loss of contracts

Executives at the lab testing giant disclosed it lost a few capitated contracts open for renewal during the second quarter due to a competitor offering lower rates than were profitable.

By David Lim • July 23, 2019

Intuitive buys Schölly's robotic endoscope business

The deal will give the robotic surgery giant control of the German company's minimally invasive visualization systems, 200 staff and three sites.

By Nick Paul Taylor • July 16, 2019

Hill-Rom to sell surgical consumables unit for $170M

The transaction will free Hill-Rom​ of a stagnant business and its 500 employees, while giving it more cash to spend on acquisitions.

By Nick Paul Taylor • July 11, 2019

Varian, Boston Scientific seal the deal on beads business transfer

Varian Medical Systems said Wednesday it completed the $90 million purchase of Boston Scientific's drug-loadable microspheres and bland embolic beads, a transaction key to Boston Scientific's buyout of BTG finalized Monday.

By Maria Rachal • Updated Aug. 21, 2019

As digital health investing matures, report says sector dodges a bubble

Venture fund and research firm Rock Health said the pace of investment dollars flowing into the sector may top 2018’s record funding as a digital health IPO drought appears on the verge of ending.

By Susan Kelly • July 2, 2019

AbbVie to buy Allergan in $63B deal

The cash-and-stock agreement, which values Allergan shares at a 45% premium to Monday's close, delivers a forceful answer to shareholder questions on AbbVie's future beyond its top-selling drug Humira. 

By Ned Pagliarulo • Updated June 25, 2019

Hologic moves to acquire French ultrasound company

SuperSonic Imagine makes a cart-based device used for supplemental testing in women with dense breast tissue.

By Susan Kelly • June 24, 2019

Thermo Fisher buys mass spec software partner HighChem

HighChem, which has worked with Thermo Fisher for 20 years, lists Pfizer, Roche and Sanofi among its customers.

By Nick Paul Taylor • June 7, 2019

Beckman Coulter buys Cytobank to add data analysis software

The Danaher-owned company said the software will complement its flow cytometer and help manage more complex workflows.

By Nick Paul Taylor • June 5, 2019

Varian ups presence in India with $283M acquisition

The Palo Alto, California-based radiation oncology systems maker will acquire Cancer Treatment Services International, which operates a network of care facilities concentrated in South Asia.

By Maria Rachal • May 21, 2019

Medtronic finalizes Titan Spine deal

The medtech giant will gain a portfolio of titanium interbody implants, bought for an undisclosed amount.

By Maria Rachal • Updated June 27, 2019

Takeda sells TachoSil patch to J&J's Ethicon for $400M

TachoSil, a surgical patch to control bleeding, contributed $155 million in net sales to the Japanese drugmaker's coffers during fiscal year 2018.

By David Lim • May 9, 2019

Boston Scientific closes acquisition of spinal device in $465M deal

Vertiflex's decompression system, designed to reduce pain in patients with lumbar spinal stenosis, is the company's first acquisition of 2019.

By Maria Rachal • Updated June 12, 2019

FTC judge upholds unraveling of microprocessor prosthetic knee firms deal

Ottobock must sell off its recent acquisition of microprocessor prosthetic knee maker Freedom Innovations over FTC's market concentration concerns.

By Dana Elfin • Updated May 8, 2019

Boston Scientific wins FDA approval for Vici stent

The go-ahead creates competition for BD's Venovo stent, approved in March. Cook Medical and Medtronic are currently working to get their own versions to market.

By David Lim • May 6, 2019

3M completes $6.7B takeout of Acelity

The deal adds new advanced wound care and specialty surgical application offerings to the Minnesota conglomerate's medical business.

By Maria Rachal • Updated Oct. 11, 2019

Alcon spin-out marks step in Novartis plan to remake business

Alcon will rank as one of the largest eye care device makers globally, with more than 20,000 employees and sales totaling $7.1 billion last year. 

By Ned Pagliarulo • April 9, 2019

J&J closes Auris Health buy, Advanced Sterilization Products divestiture

Auris' Monarch Platform adds another robotic surgery system to J&J's lineup as the medtech giant bets on digital surgery as a growth driver.

By David Lim • April 2, 2019

Q1'19 digital health investments slow, but IPOs brewing

The latest data from Rock Health shows M&A was also down, with 21 acquisitions compared to quarterly averages of 31 deals in recent years.

By Maria Rachal • April 2, 2019

Smith & Nephew picks up pressure injury prevention device

The medtech said Wednesday it completed its acquisition of Leaf Healthcare, following a two-year partnership with the wireless patient monitoring system startup.

By Maria Rachal • Updated April 17, 2019

Private equity sees ripe opportunity in healthcare this year

Potential targets include orthopaedics, gastroenterology and urology practices and mental health and addiction services, analysts say.

By Samantha Liss • March 25, 2019

Stryker to spend up to $220M on rotator cuff tear tech

The Kalamazoo, Michigan-based medtech announced it has closed a deal with Israeli startup OrthoSpace, which formerly drew investment from Johnson & Johnson and Smith & Nephew.

By Maria Rachal • March 14, 2019